Live from the NIH registry
Studies recruiting near Scranton right now
Top 25 of 98 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi)
· Sponsor: SWOG Cancer Research Network
His-Bundle Corrective Pacing in Heart Failure
Right Bundle-Branch Block, Heart Failure
N/A
Interventional 120 participants sought
Geisinger Wyoming Valley — Wilkes-Barre, Pennsylvania (15.7 mi)
· Sponsor: University of Rochester
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Eastern Cooperative Oncology Group
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Lyme Disease
Phase 3
Interventional 1,712 participants sought
Northeast Clinical Trials Group — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Pfizer
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Metastatic Breast Cancer
Phase 3
Interventional 500 participants sought
Capital Health Hematology Oncology Specialists — Newton, Pennsylvania (17.3 mi)
· Sponsor: American Society of Clinical Oncology
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
Scranton Medical Institutes — Moosic, Pennsylvania (5.2 mi)
· Sponsor: LivaNova
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: SWOG Cancer Research Network
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Lymphoma, Malignant Solid Neoplasm
Phase 3
Interventional 668 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: University of Rochester
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi)
· Sponsor: NRG Oncology
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Eye Care Specialists - Kingston — Kingston, Pennsylvania (15.6 mi)
· Sponsor: Amgen
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
GastroIntestinal Bleeding
N/A
Observational 3,000 participants sought
The Wright Center for Graduate Medical Education, 501 S. Washington Avenue — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Xingshun Qi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 3
Interventional 1,978 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi)
· Sponsor: National Cancer Institute (NCI)
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Wilkes-Barre, Pennsylvania (15.7 mi)
· Sponsor: Medtronic
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Northeast Radiation Oncology Center — Dunmore, Pennsylvania (2.0 mi)
· Sponsor: NRG Oncology
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Vivistim Registry for Paired VNS Therapy (GRASP)
Upper Extremity Problem
N/A
Observational 1,000 participants sought
Allied Services Institute of Rehabilitation Medicine — Scranton, Pennsylvania (0.3 mi)
· Sponsor: MicroTransponder Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: SWOG Cancer Research Network
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi)
· Sponsor: PrECOG, LLC.